Effects of strontium ranelate on bone mass and bone turnover in women with thalassemia major-related...
Effects of strontium ranelate on bone mass and bone turnover in women with thalassemia major-related osteoporosis
About this item
Full title
Author / Creator
Publisher
Tokyo: Springer Japan
Journal title
Language
English
Formats
Publication information
Publisher
Tokyo: Springer Japan
Subjects
More information
Scope and Contents
Contents
Subjects affected by thalassemia major (TM) often have reduced bone mass and increased fracture risk. Strontium ranelate (SrR) is an effective treatment for postmenopausal and male osteoporosis. To date, no data exist on the use of SrR in the treatment of TM-related osteoporosis. Our aim was to evaluate the effects of SrR on bone mineral density (B...
Alternative Titles
Full title
Effects of strontium ranelate on bone mass and bone turnover in women with thalassemia major-related osteoporosis
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1827917134
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1827917134
Other Identifiers
ISSN
0914-8779
E-ISSN
1435-5604
DOI
10.1007/s00774-015-0689-8
